Isn't it amazing how some can understand that and others are not willing to accept it. It will most likely be used off label for all mapping needs long before approvals for other assignments are completed with the FDA
No question there is a market but it may be worth only 1.5 dollars a share if estimate of sales and costs are correct. The real money comes in when all the other products come in if approved. Jmho i am not "shorting" anything here. Worrisome are two facts: the stock did not move after approval and the manipulation of its price in the presence of high short interests: these are facts not projections.